Beijing, China

Ruibin Su


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Ruibin Su**

Introduction

Ruibin Su, an innovative inventor based in Beijing, China, has made significant contributions to the field of pharmacology and toxicology. With a total of two patents to his name, Su focuses on the development of compounds that target the dopamine D3 receptor, which play a crucial role in various central nervous system functions.

Latest Patents

Ruibin Su's latest inventions include a novel piperazine derivative that regulates the dopamine D3 receptor. This invention encompasses stereoisomers and pharmaceutically acceptable salts or solvates. In detail, it incorporates a pharmaceutical composition comprising the compound and outlines a process for preparing it. The applications of this invention are extensive, ranging from the prevention and treatment of diseases associated with central nervous system dysfunction, such as Parkinson's disease and schizophrenia, to applications in drug addiction and relapse prevention. Additionally, it holds potential for kidney protection, immunoregulation, and as a research tool for studying D3 receptor function.

Career Highlights

Ruibin Su has worked extensively within esteemed institutions, specifically at the Institute of Pharmacology and Toxicology of the Academy of Military Medical Science, People's Liberation Army of China. His dedication to research and development in pharmacological applications showcases his commitment to advancing medical science.

Collaborations

Throughout his career, Ruibin Su has collaborated with notable coworkers, including Jin Li and Rifang Yang. These collaborations likely enhance his innovative processes and contribute to the impact of his research in the field.

Conclusion

Ruibin Su exemplifies the spirit of innovation within the pharmaceutical industry. His patents related to dopamine D3 receptor ligands represent significant strides towards addressing critical health issues. As he continues to pursue advancements in medicine, Su remains an inspiring figure in the realm of inventors, highlighting the essential role of research and innovation in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…